FDA-approved cellular and gene therapy products
All 55 products on FDA's list, searchable and grouped for clinicians and researchers, with links to the outcome data.
Source: FDA CBER, Approved Cellular and Gene Therapy Products, retrieved November 15, 2026. The groups are this portal's own and are not an FDA classification. Check the FDA page and each product's label for indications and current status.
55 products shown
| Product | Proper / generic name | Manufacturer | Group | Evidence |
|---|---|---|---|---|
| ABECMA | idecabtagene vicleucel | Celgene Corporation, a Bristol-Myers Squibb Company | T-cell / immune cell | Outcomes → |
| ADSTILADRIN | nadofaragene firadenovec-vncg | Ferring Pharmaceuticals A/S | Gene therapy (non-cell) | See FDA label |
| ALLOCORD | HPC, Cord Blood | SSM Cardinal Glennon Children's Medical Center | Stem / progenitor cell | Outcomes → |
| AMTAGVI | lifileucel | Iovance Biotherapeutics, Inc. | T-cell / immune cell | Outcomes → |
| AUCATZYL | obecabtagene autoleucel | Autolus Limited | T-cell / immune cell | Outcomes → |
| BEQVEZ | fidanacogene elaparvovec-dzkt | Pfizer, Inc. | Gene therapy (non-cell) | See FDA label |
| BREYANZI | lisocabtagene maraleucel | Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | T-cell / immune cell | Outcomes → |
| CARVYKTI | ciltacabtagene autoleucel | Janssen Biotech, Inc. | T-cell / immune cell | Outcomes → |
| CASGEVY | exagamglogene autotemcel [exa-cel] | Vertex Pharmaceuticals Incorporated | Gene-modified stem cell | Outcomes → |
| CLEVECORD | HPC, Cord Blood | Cleveland Cord Blood Center | Stem / progenitor cell | Outcomes → |
| Ducord | HPC, Cord Blood | Duke University School of Medicine | Stem / progenitor cell | Outcomes → |
| ELEVIDYS | delandistrogene moxeparvovec-rokl | Sarepta Therapeutics, Inc. | Gene therapy (non-cell) | See FDA label |
| ENCELTO | revakinagene taroretcel-lwey | Neurotech Pharmaceuticals, Inc. | Tissue & other cell | Outcomes → |
| FAYUVI | rebisufligene etisparvovec-hopf | Ultragenyx Pharmaceutical Inc. | Gene therapy (non-cell) | See FDA label |
| GENGLYCOS | pariglasgene brecaparvovec-opnr | Ultragenyx Pharmaceutical Inc. | Gene therapy (non-cell) | See FDA label |
| GINTUIT | Allogeneic Cultured Keratinocytes and Fibroblasts in Bovine Collagen | Organogenesis Incorporated | Tissue & other cell | Outcomes → |
| HEMACORD | HPC, Cord Blood | New York Blood Center | Stem / progenitor cell | Outcomes → |
| HEMGENIX | etranacogene dezaparvovec-drlb | CSL Behring LLC | Gene therapy (non-cell) | See FDA label |
| HPC, Cord Blood | HPC, Cord Blood | Clinimmune Labs, University of Colorado Cord Blood Bank | Stem / progenitor cell | Outcomes → |
| HPC, Cord Blood - Bloodworks | HPC, Cord Blood | Bloodworks | Stem / progenitor cell | Outcomes → |
| HPC, Cord Blood - LifeSouth | HPC, Cord Blood | LifeSouth Community Blood Centers, Inc. | Stem / progenitor cell | Outcomes → |
| HPC, Cord Blood - MD Anderson | HPC, Cord Blood | MD Anderson Cord Blood Bank | Stem / progenitor cell | Outcomes → |
| IMLYGIC | talimogene laherparepvec | BioVex, Inc., a subsidiary of Amgen Inc. | Gene therapy (non-cell) | See FDA label |
| ITVISMA | onasemnogene abeparvovec-brve | Novartis Gene Therapies, Inc. | Gene therapy (non-cell) | See FDA label |
| KEBILIDI | eladocagene exuparvovec-tneq | PTC Therapeutics | Gene therapy (non-cell) | See FDA label |
| KRESLADI | marnetegragene autotemcel | Rocket Pharmaceuticals, Inc. | Gene-modified stem cell | Outcomes → |
| KYMRIAH | tisagenlecleucel | Novartis Pharmaceuticals Corporation | T-cell / immune cell | Outcomes → |
| LANTIDRA | donislecel | CellTrans Inc. | Tissue & other cell | Outcomes → |
| LAVIV | Azficel-T | Fibrocell Technologies | Tissue & other cell | Outcomes → |
| LENMELDY | atidarsagene autotemcel | Orchard Therapeutics (Europe) Limited | Gene-modified stem cell | Outcomes → |
| LUXTURNA | voretigene neparvovec-rzyl | Spark Therapeutics, Inc. | Gene therapy (non-cell) | See FDA label |
| LYFGENIA | lovotibeglogene autotemcel [lovo-cel] | bluebird bio, Inc. | Gene-modified stem cell | Outcomes → |
| MACI | Autologous Cultured Chondrocytes on a Porcine Collagen Membrane | Vericel Corp. | Tissue & other cell | Outcomes → |
| OMISIRGE | omidubicel-onlv | Gamida Cell Ltd. | Stem / progenitor cell | Outcomes → |
| OTARMENI | lunsotogene parvec cwha | Regeneron Pharmaceuticals, Inc. | Gene therapy (non-cell) | See FDA label |
| PAPZIMEOS | zopapogene imadenovec-drba | Precigen, Inc. | Gene therapy (non-cell) | See FDA label |
| PROVENGE | sipuleucel-T | Dendreon Corp. | T-cell / immune cell | Outcomes → |
| REGENECYTE | HPC, Cord Blood | StemCyte, Inc. | Stem / progenitor cell | Outcomes → |
| RETHYMIC | allogeneic processed thymus tissue – agdc | Enzyvant Therapeutics GmbH | Tissue & other cell | Outcomes → |
| ROCTAVIAN | valoctocogene roxaparvovec-rvox | BioMarin Pharmaceutical Inc | Gene therapy (non-cell) | See FDA label |
| RYONCIL | remestemcel-L-rknd | Mesoblast, Inc. | Stem / progenitor cell | Outcomes → |
| SKYSONA | elivaldogene autotemcel | bluebird bio, Inc. | Gene-modified stem cell | Outcomes → |
| STRATAGRAFT | allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen-dsat | Stratatech Corporation | Tissue & other cell | Outcomes → |
| SYMVESS | acellular tissue engineered vessel-tyod | Humacyte Global, Inc. | Tissue & other cell | Outcomes → |
| TECARTUS | brexucabtagene autoleucel | Kite Pharma, Inc. | T-cell / immune cell | Outcomes → |
| TECELRA | afamitresgene autoleucel | Adaptimmune LLC | T-cell / immune cell | Outcomes → |
| TREGZI | Allogeneic regulatory T cell immunotherapy with HSPC and T cells-vldq | Orca Biosystems Inc | Stem / progenitor cell | Outcomes → |
| TUDRIQEV | vusolimogene oderparepvec-wtpg | Replimune, Inc. | Gene therapy (non-cell) | See FDA label |
| VOCERYQ | doruxapapogene ralaplasmid and lalikinogene sifuplasmid-gxfd | Alliance Medical Products Inc. dba Siegfried (AMP), Irvine, CA | Gene therapy (non-cell) | See FDA label |
| VYJUVEK | beremagene geperpavec-svdt | Krystal Biotech, Inc. | Gene therapy (non-cell) | See FDA label |
| WASKYRA | etuvetidigene autotemcel | Fondazione Telethon ETS | Gene-modified stem cell | Outcomes → |
| YESCARTA | axicabtagene ciloleucel | Kite Pharma, Incorporated | T-cell / immune cell | Outcomes → |
| ZEVASKYN | prademagene zamikeracel | Abeona Therapeutics, Inc. | Tissue & other cell | Outcomes → |
| ZOLGENSMA | onasemnogene abeparvovec-xioi | Novartis Gene Therapies, Inc. | Gene therapy (non-cell) | See FDA label |
| ZYNTEGLO | betibeglogene autotemcel | bluebird bio, Inc. | Gene-modified stem cell | Outcomes → |